Case studies.
Representative engagements across reimbursement, market access, and investor diligence. Detailed write-ups are shared under NDA on request.
TruDiagnostic
Advised TruDiagnostic on sequencing the full coding-to-payment lifecycle for its methylation-based testing platform.
Infinite Epigenetics
Partnered with Infinite Epigenetics on commercial strategy, coding pathway, and payer engagement.
Nano Dimension
Evaluated the U.S. reimbursement landscape for Nano Dimension's healthcare-adjacent device applications.
Houlihan Lokey
Independent, decision-ready reimbursement diligence supporting a publicly traded acquirer evaluating a commercial-stage molecular diagnostics target.
Oneness Biotech
End-to-end commercialization plan for a foreign manufacturer entering the U.S. wound-care market — sequenced around reimbursement reality.
Have a comparable challenge?
Tell us about your product, stage, and audience. We'll respond with a candid view.